Moguisteine (BBR-2173) is a novel, peripherally-acting non-narcotic antitussive agent. It is utilized in respiratory research to investigate cough suppression mechanisms, with studies demonstrating its efficacy in both in vitro assays and in vivo animal models of experimentally induced cough.
